Advanced search
Publication Cover
International Journal of Neuroscience Volume 131, 2021 - Issue 12
Submit an article Journal homepage
280
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children

Marianna Makowskaa Helios Klinikum Bad Saarow, Bad Saarow, GermanyView further author information
,
Beata Smolarzb Laboratory of Cancer Genetics, Department of Pathology, Polish Mother’s Memorial Hospital Research Institute, Lodz, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3168-062XView further author information
ORCID Icon,
Magdalena Bryśc Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, PolandView further author information
,
Ewa Formac Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, PolandView further author information
&
Hanna Romanowiczb Laboratory of Cancer Genetics, Department of Pathology, Polish Mother’s Memorial Hospital Research Institute, Lodz, PolandView further author information
Pages 1147-1154 | Received 09 Mar 2020, Accepted 04 Jun 2020, Published online: 30 Jun 2020

References

  • Manford M. Recent advances in epilepsy. J Neurol. 2017;264(8):1811–1824.
  • Udani V. Pediatric epilepsy - an Indian perspective. Indian J Pediatr. 2005;72(4):309–313.
  • Kozera-Kępniak A, Jastrzębski K, Klimek A. Pharmacogenetic determinants of drug resistance in epilepsy. Aktualn Neurol. 2013; 13:96–102.
  • Lazarowski A, Czornyj L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions. Drug Metabol Drug Interact. 2011;26(1):21–26.
  • Emich-Widera E, Likus W, Kazek B, et al. CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents. Biomed Res Int. 2013;2013:526837.
  • Ghosh C, Hossain M, Solanki J, et al. Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells. Epilepsia. 2017;58(4):576–585.
  • Ke XJ, Cheng YF, Yu N, et al. Effects of carbamazepine on the P-gp and CYP3A expression correlated with PXR or NF-κB activity in the bEnd.3 cells. Neurosci Lett. 2019; 690:48–55.
  • Lin JH, Lu AY. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev. 1997;49(4):403–449.
  • Pierzchała K. Padaczka oporna na leczenie – epidemiologia i aktualny stan badań. Neurol Neurochir Pol. 2010;44(3):285–290.
  • Brandolese R, Scordo MG, Spina E, et al. Severe phenytoin intoxication in a subject homozygous for CYP2C9*3. Clin Pharmacol Ther. 2001;70(4):391–394.
  • van der Weide J, Steijns LS, van Weelden MJ, et al. The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement. Pharmacogenetics. 2001;11:287–291.
  • Watanabe M, Iwahashi K, Kugoh T, et al. The relationship between phenytoin pharmacokinetics and the CYP2C19 genotype in Japanese epileptic patients. Clin Neuropharmacol. 1998;21(2):122–126.
  • Scordo MG, Aklillu E, Yasar U, et al. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population. Br J Clin Pharmacol. 2001;52(4):447–450.
  • Franco V, Perucca E. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. Expert Opin Drug Metab Toxicol. 2015;11(8):1269–1279.
  • Suvichapanich S, Jittikoon J, Wichukchinda N, et al. Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children. J Hum Genet. 2015;60(8):413–417.
  • Kousar S, Wafai ZA, Wani MA, et al. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance. Int J Clin Pharmacol Ther. 2015;53(7):504–516.
  • Chan BS, Sellors K, Chiew AL, et al. Use of multi-dose activated charcoal in phenytoin toxicity secondary to genetic polymorphism. Clin Toxicol (Phila). 2015;53(2):131–133.
  • Remy S, Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain. 2006;129(Pt 1):18–35.
  • Löscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther. 2002;301(1):7–14.
  • Spear BB. Pharmacogenetics and antiepileptic drugs. Epilepsia. 2001;42(s5):31–34.
  • Marroni M, Marchi N, Cucullo L, et al. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. Curr Drug Targets. 2003;4(4):297–304.
  • Patsalos PN. Antiepileptic drug pharmacogenetics. Ther Drug Monit. 2000;22(1):127–130.
  • López-García MA, Feria-Romero IA, Serrano H, et al. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy. Pharmacol Rep. 2017;69(3):504–511.
  • Seven M, Batar B, Unal S, et al. The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children. Mol Diagn Ther. 2014;18(2):229–236.
  • Lakhan R, Kumari R, Singh K, et al. Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy. Indian J Med Res. 2011;134:295–301.
  • Dagenais R, Wilby KJ, Elewa H, et al. Impact of genetic polymorphisms on phenytoin pharmacokinetics and clinical outcomes in the Middle East and North Africa Region. Drugs R D. 2017;17(3):341–361.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.